Global pulmonary function testing market growth is driven by rising prevalence of chronic respiratory diseases, increasing geriatric population, and growing adoption of diagnostic monitoring ...
Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.
Are you feeling out of breath while talking or climbing stairs These silent symptoms may be the first signs of COPD that one ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
Discover how actuarial value determines cost-sharing in health insurance, affecting premiums and out-of-pocket expenses ...